Results 251 to 260 of about 115,232 (278)

A Case of Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus Achieving Pathologic Complete Response Following Combination Therapy With Lenvatinib and Pembrolizumab. [PDF]

IJU Case Rep
Takayama H, Sano T, Hirao K, Motoki Y, Taniguchi H, Yanishi M, Uchida K, Kinoshita H.   +7 more
europepmc   +1 more source

The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance. [PDF]

Transl Lung Cancer Res
Gao C, Chen J, Pang B, Su C.
europepmc   +1 more source

Novel genes involved in the pathogenesis of Insulin-resistance: new targets for the treatment of Type 2 Diabetes Mellitus

, 2007
Cassese, Angela
core  

Chemotherapy in combination with KRAS inhibitors in <i>KRAS</i>-mutated non-small cell lung cancer. [PDF]

J Thorac Dis
Rosell R, González-Cao M.
europepmc   +1 more source

Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology. [PDF]

Oncol Res
Manan A, Ilyas S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Protein expression of programmed cell death ligand 1 and ligand 2 and their prognostic values in extensive-stage small cell lung cancer.

Journal of Clinical Oncology, 2021
e20593 Background: The receptor-ligand interaction between programmed cell death protein-1 (PD-1) and its ligands (PD-L1 and PD-L2) plays a critical role in tumor immune evasion and has become a therapeutic target in a number of cancer types, including extensive stage small cell lung cancer (ES-SCLC).
Ke (Kirsten) Zu, Jeanette Bæhr Georgsen, Peter Meldgaard, Anne Deitz, Mark Ayers, Maria Catherine Pietanza, Torben Steiniche   +6 more
openaire   +1 more source

Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity

Lupus, 2020
Objective Programmed cell death protein 1 (PD-1) pathway plays important roles in systemic lupus erythematosus (SLE). We aimed to elucidate the association of serum soluble PD-1 (sPD-1) and related molecules with SLE and to explore their usefulness as biomarkers.
Shinya Hirahara, Yasuhiro Katsumata, Hidenaga Kawasumi, Yashushi Kawaguchi, Masayoshi Harigai   +4 more
openaire   +2 more sources

Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC

Journal of Thoracic Oncology, 2021
Masayuki Shirasawa, Hidehito Horinouchi, Takashi Kohno   +2 more
exaly  

Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis

Cancer Treatment Reviews, 2021
Keiichiro Mori, Benjamin Pradère, Fahad Quhal   +2 more
exaly